Company / Shareholders' Equity
NextCure, Inc. Shareholders' Equity History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$293.7M
FY2021
5-year range
-$46.9M / $321.5M
FY2019-FY2021
Trend
-8.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$47M to $294M over the past 2 years.
Based on SEC 10-K filings.
$294M in FY2021.
Improved from -$47M to $294M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, shareholders' equity decreased 8.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $293.7M | -8.6% |
| FY2020 | $321.5M | +784.8% |
| FY2019 | -$46.9M | - |
As of FY2021 · SEC 10-K Annual Filings · Updated Jun 28, 2026